Celanese Corporation

Equities

CE

US1508701034

Specialty Chemicals

Market Closed - Nyse 04:00:02 2024-04-19 pm EDT 5-day change 1st Jan Change
154.4 USD -0.11% Intraday chart for Celanese Corporation -1.02% -0.59%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
RBC Raises Price Target on Celanese to $171 From $165, Keeps Outperform Rating MT
Celanese Keeps Quarterly Dividend at $0.70 a Share, Payable May 13 to Stockholders of Record April 29 MT
Celanese Corporation Declares Quarterly Dividend, Payable on May 13, 2024 CI
BofA Securities Raises Price Target on Celanese to $145 From $135, Maintains Underperform Rating MT
KeyBanc Raises Price Target on Celanese to $190 From $176, Keeps Overweight Rating MT
UBS Raises Celanese's Price Target to $199 From $175, Maintains Buy Rating MT
North American Morning Briefing : Investors on -2- DJ
JPMorgan Downgrades Celanese to Underweight From Neutral, Raises Price Target to $160 From $135 MT
ANALYST RECOMMENDATIONS : Block, Chubb, Doordash, Coinbase, Lloyds... Our Logo
Wells Fargo Raises Price Target on Celanese to $195 From $180, Maintains Overweight Rating MT
Celanese and Secarna Pharmaceuticals Enter into RNA Research Collaboration for Long-Acting Antisense Therapies CI
William M. Brown Announces Not Stand for Re-Election to the Board of Celanese Corporation CI
Just as expected Our Logo
ANALYST RECOMMENDATIONS : Amex, Snowflake, Salesforce, Walmart, Nutrien... Our Logo
Celanese Corporation Elects Timothy Go to Board of Directors CI
North American Morning Briefing : Stock Futures -2- DJ
Celanese Earnings Likely to Improve in 2024 Despite Demand Headwinds, RBC Says MT
Deutsche Bank Adjusts Celanese Price Target to $160 From $125, Maintains Hold Rating MT
How long will this bullish phase last? Our Logo
Piper Sandler Upgrades Celanese to Overweight From Neutral, Raises Price Target to $170 From $135 MT
RBC Trims Price Target on Celanese to $165 From $168, Notes 'Demand Headwinds' Likely to Persist Into Q1, Keeps Outperform Rating MT
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox... Our Logo
Baird Adjusts Celanese's Price Target to $165 From $135, Keeps Outperform Rating MT
JPMorgan Adjusts Celanese's Price Target to $135 From $125, Keeps Neutral Rating MT
Wells Fargo Adjusts Celanese's Price Target to $180 From $167, Keeps Overweight Rating MT
Chart Celanese Corporation
More charts
Celanese Corporation specializes in the manufacture and marketing of chemicals and specialty materials. The products are intended for the production of automotive components, beverages and food products, cigarette filters, paints and coatings, packaging, textiles, etc. Net sales by category of products break down as follows: - acetyl products (55.7%); - high performance engineering polymers (44.3%). Net sales are distributed geographically as follows: the United States (25.8%), Germany (22.6%), China (17.8%), Singapore (10.5%), Belgium (4.6%), Mexico (3.3%), Japan (2.9%), Switzerland (2%), India (1.4%), South Korea (1.4%), Brazil (1.3%), Canada (1.3%), France ( 0.8%), the United Kingdom (0.8%), Italy (0.7%), Spain (0.5%), and other (2.3%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
154.4 USD
Average target price
162 USD
Spread / Average Target
+4.89%
Consensus
  1. Stock Market
  2. Equities
  3. CE Stock
  4. News Celanese Corporation
  5. Celanese Keeps Quarterly Dividend at $0.70 a Share, Payable March 5 to Stockholders of Record Feb. 20